Study shows estrogen blocker treatment does not increase risk of coronary heart disease in breast cancer patients
New evidence shows that extended estrogen suppression treatment using aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of coronary artery calcification, ...
Sep 17, 2024
0
0